NEW YORK (GenomeWeb News) – The National Institute of Arthritis and Musculoskeletal and Skin Diseases plans to fund $100,000 for phase I and $750,000 for phase II Small Business Innovation Research grants to companies seeking to develop multiplex diagnostic tests that could apply to a variety of diseases.

NIAMS wants to fund projects that will develop multiplex assay methodologies for candidate biomarkers for musculoskeletal, rheumatic, and skin diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.